About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | The Safety And Efficacy Of Maintenance Therapy With CP-690,550

The Safety And Efficacy Of Maintenance Therapy With CP-690,550

NCT01393899·91 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subjects who met study entry criteria, and who completed Week 8 visit of Induction Study A3921083.
Subjects who achieve clinical response-100 (reduction in CDAI by 100 points) and/or clinical remission (CDAI\<150) in Study A3921083.
Women of childbearing potential must test negative for pregnancy prior to study enrolment.

You may not be if

Subjects who had major protocol violation (as determined by the Sponsor) in the A3921083 study.
Subjects likely to require any type of surgery during the study period.
Fecal culture/toxin assay indicating presence of pathogenic infection.

The record

StatusCompleted

PhasePhase 2

Taking part180

StartedMar 2012

UpdatedJan 9, 2017

Conditions

Crohn's Disease

Where91

ACMG Endoscopy Center
Anaheim, California, United States
ACRI - Phase I, LLC
Anaheim, California, United States
Advanced Clinical Research Institute-Phase 1, LLC
Anaheim, California, United States